ArticleResearch in pharmaceutical sciences2026
The combination of rosuvastatin and meloxicam enhances the radiotherapy efficacy of MCF7, T-47D, and MDA-MB-231 breast cancer cell lines.
Arvin Naeimi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.